Repligen (RGEN) Shares Drop 6% Following $1.5B BioLife Solutions Acquisition Announcement

Repligen (RGEN) stock dropped 5.84% after unveiling a $1.5B deal to acquire BioLife Solutions (BLFS) at $31/share with cash and stock combination.

The post Repligen (RGEN) Shares Drop 6% Following $1.5B BioLife Solutions Acquisition Announcement appeared first on Blockonomi.